speaker-photo

Waleed Alsalawi πŸ‡ΈπŸ‡¦

Consultant Medical Oncologist with extensive experience in cancer management, clinical research, and medical education. Actively involved in oncology fellowship training, international research collaborations, and multidisciplinary cancer care.

13:45 - 14:00

Day 1 Scientific Program - Day 1

First-Line Maintenance Strategies in Advanced Ovarian Cancer: Where Do PARP Inhibitors Stand in 2025? (Evolving role of PARP after SOLO1/PRIMA/ATHENA updates)